Strength Seen in ZIOPHARM Oncology (ZIOP): Stock Up 11.8% - Tale of the Tape - Alkermes (NASDAQ:ALKS)

ZIOPHARM Oncology, Inc. ZIOP was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.10 to $4.64 in the past one-month time frame.

The company has seen one positive estimate revision over the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

ZIOPHARM currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Investors interested in the medical industry may consider stocks like ANI Pharmaceuticals, Inc. ANIP, Alexion Pharmaceuticals, Inc. ALXN and Alkermes plc ALKS. All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALKERMES INC ALKS: Free Stock Analysis Report

ALEXION PHARMA ALXN: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs